Normal plasma insulin-like growth factor I levels and impaired final stature in adult blind subjects.
The aim of this study was to determine if changes in IGF-1 levels and in final stature occur in blind adult subjects. Eighteen subjects (4 females and 14 males) with total blindness (Group 1) and 26 subjects (5 females and 21 males) with only light perception (Group 2), living at an Institute for blind adult subjects in Naples, Italy, were studied. Their height and weight were compared to British standards. Plasma morning IGF-1 levels, measured by IRMA method were compared to those of 18 normal controls (6 females and 12 males) matched for age and weight. A high prevalence of short stature was demonstrated especially in Group 1 (p = 0.00005 by chi-square for trend test) but was also present in Group 2 (p = 0.02). No alterations in weight distribution were observed in both groups. Basal IGF-I levels in both Group 1 and Group 2 were similar to those of controls: IGF-1 (M +/- SE), 30.9 +/- 2.9 nmol/L and 37.9 +/- 2.7 nmol/L, respectively, vs 33.3 +/- 2.9 nmol/L, NS. High prevalence of final short stature in both groups confirms a negative influence of total or partial blindness on growth. These complex mechanisms appear to involve more than alterations in GH and IGF-I secretion.
Bellastella
A
A
Istituto di Endocrinologia, Facoltà di Medicina e Chirurgia, II Università di Napoli, Italy.
Criscuolo
T
T
Iorio
S
S
Parlato
F
F
Sinisi
A A
AA
Sinisi
A M
AM
Pasquali
D
D
Pisano
G
G
D000328:Adult; D001766:Blindness / Q000097:blood* / Q000453:epidemiology / Q000503:physiopathology; D001827:Body Height / Q000502:physiology; D001835:Body Weight / Q000502:physiology; D005260:Female; D006130:Growth Disorders / Q000097:blood* / Q000453:epidemiology / Q000503:physiopathology; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D015592:Immunoradiometric Assay; D007334:Insulin-Like Growth Factor I / Q000032:analysis*; D007558:Italy / Q000453:epidemiology; D008297:Male; D015995:Prevalence
D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone